Results 141 to 150 of about 8,420 (193)

Evaluating Radiotheranostic Targets for Endometrial Cancer. [PDF]

J Nucl Med
Sebastiano J, McGlone SA, Samuels ZV, Grimaldi C, Stoddard A, Galka S, Colaco E, Zeglis BM.   +7 more
europepmc   +1 more source

Homotypic Targeting of [⁸⁹Zr]Zr-Oxine Labeled PC3 and 4T1 Cells in Tumor-Bearing Mice. [PDF]

Pharmaceutics
Tekin V, Archer NE, Fernandez SR, Houson HA, Bartels JL, Lapi SE.   +5 more
europepmc   +1 more source

Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates. [PDF]

Clin Cancer Res
Bidkar AP, Bidlingmaier S, Wadhwa A, Mayne E, Raveendran A, Naik S, Xue C, Basak M, Bobba KN, Patiño-Escobar B, Greenland N, Camara Serrano JA, Steri V, Chou J, Wiita A, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Liu B, Flavell RR.   +21 more
europepmc   +1 more source

TPP-45142-an Anti-HER2 T-cell Engager-Designed for Selective HER2-Low Cancer Immunotherapy. [PDF]

Mol Cancer Ther
De Tavernier E, Kim PS, Bruch EM, Cortez-Retamozo VF, Timmerman L, Flynn AL, Van Overbeke W, Tirode F, Cintra Barbosa-Lorenzi V, Piepenhagen P, Dinh-Le T, Luna E, Li A, Baker A, Rak A, Pao LI, Vintém APB.   +16 more
europepmc   +1 more source

Synthesis and preclinical development of a novel ⁶⁸Ga/⁸⁹Zr-Labelled ανβ6-integrin targeting trimer. [PDF]

EJNMMI Radiopharm Chem
Gariglio G, A Patiño Álvarez F, A Zierke M, Stangl S, Rheinfrank T, Holzleitner N, Kossatz S, Decristoforo C.   +7 more
europepmc   +1 more source

SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization. [PDF]

J Nucl Med
Rowe SP, Shuch BM, Ball MW, Bex A, Javadi MS, Klitzke A, Goffin K, Mulders P, Pandit-Taskar N, Parihar AS, Viglianti BL, Gorin MA, Herrmann K.   +12 more
europepmc   +1 more source

[⁸⁹Zr]Zr-DFO-avelumab accumulation in resectable non-small cell lung carcinoma indicates a suppressive tumor microenvironment amendable to neoadjuvant avelumab treatment. [PDF]

Immunother Adv
Verhoeff SR, van Genugten EAJ, van der Hoorn IAE, Vos S, van der Woude LL, Ciompi F, de Vries IJM, van Herpen CML, Heskamp S, Verhagen AFTM, van den Heuvel GRM, Piet B, van den Heuvel MM, Aarntzen EHJG.   +13 more
europepmc   +1 more source

Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications. [PDF]

J Nucl Med
Salerno I, Dunn N, White H, Miyazaki W, Jeziorski K, Silvestros D, Jha A, Laforest R, Akerele MI, Thomas MA, Thorek DLJ.   +10 more
europepmc   +1 more source

Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer:a cost-effectiveness study [PDF]

Buskens, Erik, de Bock, Geertruida H, de Vries, Erik F J, Feenstra, Talitha L, Greuter, Marcel J W, Koleva-Kolarova, Rositsa G, Parkin, David, Vermeulen, Karin M   +7 more
core